| Gene symbol | S | Synonyms | None | Type of gene | protein-coding |
| Chromosome | None | Map location | NC_003977.2 (2850..3182) NC_003977.2 (1..837) | dbXrefs | |
| Description | large envelope protein;middle envelope protein;small envelope protein | ||||
| GTO ID | GTC3000 |
| Trial ID | NCT05339321 |
| Disease | Hepatocellular Carcinoma |
| Altered gene | S |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | SCG101 |
| HLA | HLA-A*02 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Phase 1 Clinical Study of Autologous HBV-specific TCR-T Cell Therapy (SCG101) in Patients With HBV-related HCC |
| Year | 2022 |
| Country | China |
| Company sponsor | Peking Union Medical College Hospital |
| Other ID(s) | SCG101-CI-101 |
| Cohort 1 | |||||||||
|
|||||||||